A novel full-human CD22-CAR T cell therapy with potent activity against CD22^low B-ALL.

ABSTRACT:

SUBMITTER: Tan Y 

PROVIDER: S-EPMC8036232 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature